Holen Sie sich die Stockscreener-App
28.09
0.74%
-0.21
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt PFE?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Pfizer Inc Aktie (PFE) Neueste Nachrichten
24,909 Shares in Pfizer Inc. (NYSE:PFE) Purchased by Affinity Investment Advisors LLC - MarketBeat
PFIZER INC : UBS reiterates its Neutral rating - Marketscreener.com
Leerink Partnrs Weighs in on Pfizer's Q4 Earnings (NYSE:PFE) - MarketBeat
Pfizer Inc. (NYSE:PFE) Shares Bought by Lincluden Management Ltd. - MarketBeat
Pfizer (NYSE:PFE) Upgraded at Evercore ISI - MarketBeat
Pfizer Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next - Simply Wall St
Pfizer faces lawsuit over withdrawn sickle cell drug - Daily Journal
Pfizer Inc. (NYSE:PFE) Director Acquires $28,240.00 in Stock - MarketBeat
Is Pfizer (NYSE:PFE) a High-Yielding Dividend Stock Worth Buying? - Yahoo Finance
Pfizer director Scott Gottlieb purchases $28,240 in common stock - Investing.com
Pfizer sees strong Q3, led by revenues for Covid vaccine, Paxlovid - Healthcare Brew
Pfizer: Overstated Pessimism Makes Little Sense (NYSE:PFE) - Seeking Alpha
Pfizer presents new AMPK activators - BioWorld Online
Zacks Investment Ideas feature highlights: Pfizer, Philip Morris and Tenet Healthcare - Zacks Investment Research
Is Pfizer Stock A Sell After Covid Products Drive Surprise Upside? - Investor's Business Daily
Cantor Fitzgerald Boosts Earnings Estimates for Pfizer - MarketBeat
Results: Pfizer Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates - Yahoo Finance
Pathway Financial Advisers LLC Sells 17,982 Shares of Pfizer Inc. (NYSE:PFE) - MarketBeat
3 Factors That Make Pfizer's Ultra-High-Yield Dividend Safer Than You Might Think - The Motley Fool
Diclofenac Patches Market Is Booming Worldwide 2024-2031 | - openPR
Pfizer Inc. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
Pfizer Covid sales boost prompts durability concernsBank of America - Proactive Investors USA
Pfizer (NYSE:PFE) Stock Price Down 0.7%Here's What Happened - MarketBeat
Pfizer boasts over 30% increase in Q3 revenues against previous year - Yahoo Finance
Goldman Sachs raises Pfizer stock target, keeps buy rating on Paxlovid sales - Investing.com
Pfizer Surpasses Q3 Expectations with Strong Earnings and Revenue Surge - Yahoo Finance
Golden State Equity Partners Invests $1.04 Million in Pfizer Inc. (NYSE:PFE) - MarketBeat
Here's Why Pfizer (PFE) is a Strong Value Stock - Yahoo Finance
Pfizer Inc. Reports Strong Q3 2024 Results, Raises Guidance - MSN
Are Wall Street Analysts Predicting Pfizer Stock Will Climb Or Sink? - Barchart
Pfizer Third Quarter 2024 Earnings: Beats Expectations - Simply Wall St
Pfizer (PFE) PT Raised to $33 at Goldman Sachs - StreetInsider.com
PFIZER INC. (PFE) - MSN
Pfizer reports Q3 2024 net income of $4.46bn - World Pharmaceutical Frontiers
Pfizer Inc (PFE) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Raised Guidance - Yahoo Finance
Pfizer rebuffs Starboard criticism as it raises forecasts - pharmaphorum
Pfizer’s earnings crush estimates as company raises guidance - MSN
Pfizer (PFE) Stock Movement Driven by Activist Investor Concerns - GuruFocus.com
Why Pfizer Stock Tumbled on Tuesday - Yahoo Finance
Pfizer CEO on company's 'exceptional quarter' & Starboard fight - Yahoo Finance
Health Care Flat as Pfizer Weighs -- Health Care Roundup - Marketscreener.com
Pfizer Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Pfizer Braces for Activist Battle With Forecast Increase - MSN
Pfizer Earnings: Maintaining Our Valuation as Management Pressed for Evidence of Productivity - Morningstar
Pfizer raises full-year guidance by $1.5 billion amid activist investor pressure - Yahoo Finance
Pfizer CEO defends performance after Starboard activist criticism - Financial Times
Pfizer CEO Defends Record Against Activist Attack - Barron's
Pfizer CEO: The activist investors are 'too late' - Yahoo Finance
Pfizer sales of RSV vaccine ebb, but company gains market share - BioPharma Dive
Pfizer’s Bourla Defends Strategy In The Wake Of Starboard’s Activist Investment - Scrip
Pfizer’s Oncology Triumphs Keep Investors Hooked Amid Market Volatility - Seeking Alpha
Pfizer (PFE) Raises Forecast, Braces for Fight With Starboard - Bloomberg
Pfizer CEO, Under Fire, Will Do ‘Whatever It Takes’ to Grow (1) - Bloomberg Law
Pfizer’s Strong Quarter Bolsters CEO’s Comeback Efforts - The Wall Street Journal
Pfizer Results May Temper Efforts for Shakeup Demanded by Activist Investor - Investopedia
Pfizer (NYSE:PFE) Shares Down 2.4%What's Next? - MarketBeat
Key takeaways from Pfizer’s (PFE) Q3 2024 earnings report - AlphaStreet
Pfizer Delivers Knockout Q3 Earnings Results, But Investors Are Unimpressed - Seeking Alpha
Trending : Pfizer Raises Guidance After Strong 3Q - Marketscreener.com
Trending: Pfizer Raises Guidance After Strong 3Q - Morningstar
Why is Pfizer stock falling after Q3 results? (PFE:NYSE) - Seeking Alpha
Pfizer rides Paxlovid sales growth to better than expected third quarter - CNA
Pfizer’s guidance bump will not heal deeper wounds - Financial Times
Pfizer CEO, Under Fire, Will Do ‘Whatever It Takes’ to Grow | Company Business News - Mint
Ford Q3 earnings, Pfizer outlook amid Starboard fight: Morning Brief - Yahoo Finance
Pfizer CEO defends turnaround strategy as activist pressures management - Reuters
Nasdaq Surges Over 100 Points; Pfizer Earnings Top ViewsPfizer (NYSE:PFE) - Benzinga
0.29%
0.74%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):